Serotonin and cholecystokinin synergistically stimulate rat vagal primary afferent neurones

Journal of Physiology

Volumn 559, Issue 2, 2004, Pages 651-662

  Li, Y ^a   Wu, X Y ^a   Owyang, C ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLECYSTOKININ; CHOLECYSTOKININ A RECEPTOR; CHOLECYSTOKININ OCTAPEPTIDE; LORGLUMIDE; N TERT BUTYLOXYCARBONYLCHOLECYSTOKININ[27-32][28,31 NORLEUCINE] PHENETHYL ESTER; SEROTONIN; SEROTONIN RECEPTOR; ATROPINE; HEXAMETHONIUM; SEROTONIN 3 RECEPTOR;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; ELECTROPHYSIOLOGY; GASTROINTESTINAL TRACT FUNCTION; INTESTINE DISTENSION; INTESTINE INNERVATION; INTESTINE PERFUSION; MUSCLE SPINDLE AFFERENT NERVE; NERVE CELL MEMBRANE POTENTIAL; NODOSE GANGLION; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR AFFINITY; VAGUS NERVE STIMULATION; ADULT; CONCENTRATION RESPONSE; DUODENUM; MALE; SENSORY NERVE; VAGUS NERVE;

ACTION POTENTIALS; ANIMALS; CHOLECYSTOKININ; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; MALE; NEURONS, AFFERENT; RATS; RATS, SPRAGUE-DAWLEY; SEROTONIN; VAGUS NERVE;

EID: 4444364428     PISSN: 00223751     EISSN: None     Source Type: Journal    
DOI: 10.1113/jphysiol.2004.064816     Document Type: Article

References (39)

1. 3 receptors in the anaesthetized ferret. J Physiol 422, 92P.
2. Attoub S, Moizo L, Laignwau JP, Alchepo B, Lewin MJ & Bado A (1998). YM022, a highly potent and selective CCKB antagonist inhibiting gastric acid secretion in the rat, the cat and isolated rabbit glands. Fundam Clin Pharmacol 12, 256-262.
3. Blackshaw LA & Grundy D (1993). Effects of 5-hydroxytryptamine on discharge of vagal mucosal afferent fibres from the upper gastrointestinal tract of the ferret. J Auton Nerv Syst 45, 41-50.
4. Bueno L, Fioramonti J, Delvaux M & Frexinos J (1997). Mediators and pharmacology of visceral sensitivity: from basic to clinical investigations. Gastroenterology 112, 1714-1743.
5. Cox JE (1994). Duodenal sucrose and glucose infusions enhance suppression by cholecystokinin of sham feeding. Am J Physiol 266, R466-R471.
6. Cox JE (1998). Cholecystokinin satiety involves CCKA receptors perfused by the superior pancreaticoduodenal artery. Am J Physiol 274, R1390-R1396.
7. Davison JS & Clarke GD (1988). Mechanical properties and sensitivity to CCK of vagal gastric slowly adapting mechanoreceptors. Am J Physiol 255, G55-G61.
8. De Ponti F & Tonini M (2001). Irritable bowel syndrome: new agents targeting scrotonin receptor subtypes. Drugs 61, 317-332.
9. Emeran AE & Gebhart GF (1994). Basic and clinical aspects of visceral hyperalgesia. Gastroenterology 107, 271-293.
10. Grider JR, Foxx-Orenstein AE & Jin JG (1998). 5-Hydroxytryptamine 4 receptor agonists initiate the peristaltic reflex in human, rat, and guinea pig intestine. Gastroenterology 115, 370-380.
11. Hebel R & Stromberg RW (1976). Anatomy of Laboratory Rat. Williams & Wilkins, Baltimore.
12. Hillsley K & Grundy D (1998). Serotonin and cholecystokinin activate different populations of rat mesenteric vagal afferents. Neurosci Lett 225, 63-66.
13. Julian GM & Lawrence CB (1992). Selectivity of cholecystokinin (CCK) receptor antagonists, MK-329 and L-365,260, for axonally-transported CCK binding sites on the rat vagus nerve. Neurosci Lett 137, 229-231.
14. 2+ signal transduction in vagal nodose ganglia. Am J Physiol Gastrointest Liver Physiol 282, G1002-G1008.
15. Li Y, Hao Y & Owyang C (1997). High-affinity CCK-A receptors on the vagus nerve mediate CCK-stimulated pancreatic secretion in rats. Am J Physiol 273, G679-G685.
16. Li Y, Hao YB, Zhu JX & Owyang C (2000). Serotonin released from intestinal enterochromaffin cells mediates luminal non-CCK-stimulated pancreatic secretion in rats. Gastroenterology 118, 1197-1207.
17. Li Y & Owyang C (1993). Vagal afferent pathways mediate physiological action of cholecystokinin on pancreatic secretion. J Clin Invest 92, 418-424.
18. Li Y & Owyang C (1996). Pancreatic secretion evoked by cholecystokinin and non-cholecystokinin-dependent duodenal stimuli via vagal afferent fibres in the rat. J Physiol 494, 773-782.
19. Li Y, Wu XY & Owyang C (2001). Intestinal serotonin acts as a paracrine substance to mediate pancreatic secretion stimulated by non-CCK-dependent luminal factors. Am J Physiol Gastrointest Liver Physiol 281, G916-G923.
20. Li Y, Zhu J & Owyang C (1999). Electrical physiological evidence for high- and low-affinity CCK-A receptors. Am J Physiol 277, G469-G477.
21. Mei N & Garnier L (1986). Osmosensitive vagal receptors in the small intestine of the cat. J Auton Nerv Syst 16, 159-170.
22. Ness TJ & Gebhart GF (1988). Colorectal distension as a noxious visceral stimulus: physiologic and pharmacologic characterization of pseudaffective reflexes in the rat. Brain Res 450, 153-169.
23. Niederau M, Niederau C, Strohmeyer G & Grendell JH (1989). Comparative effects of CCK receptor antagonists on rat pancreatic secretion in vivo. Am J Physiol 256, G150-G157.
24. Ozcelbi F & Miller LJ (1995). Phosphopeptide mapping of cholecystokinin receptors on agonist-stimulated native pancreatic acinar cells. J Biol Chem 270, 3435-3441.
25. Raybould HE & Hölzer HH (1992). Dual capsaicin-sensitive afferent pathways mediate inhibition of gastric emptying in rat induced by carbohydrate. Neurosci Lett 141, 236-238.
26. Renehan WE, Zhang X, Beierwaltes WH & Fogel R (1995). Neurons in the dorsal motor nucleus of the vagus may integrate vagal and spinal information from the GI tract. Am J Physiol 268, G780-G790.
27. Richards W, Hillsley K, Eastwood C & Grundy D (1996). Sensitivity of vagal mucosal afferents to cholecystokinin and its role in afferent signal transduction in the rat. J Physiol 497, 473-481.
28. Ritter RC, Brenner L & Yox DP (1992). Participation of vagal sensory neurons in putative satiety signals from upper gastrointestinal tract. In Neuroanatomy and Physiology of Abdominal Vagal Afferents. ed. Ritter S, Ritter RC & Barnes CD, pp. 221-248. CRC Press, Boca Raton, Ann Arbor, Boston.
29. Roberts-Thomson IC, Fettman MJ, Jonsson JR & Frewin DB (1992). Responses to cholecystokinin octapeptide in patients with functional abdominal pain syndromes. J Gastroenterol Hepatol 7, 293-297.
30. Sato S, Stark HA, Martines J, Beaven MA, Jensen RT & Gardner JD (1989). Receptor occupation, calcium mobilization and amylase release in pancreatic acini: effect of CCK-JMV-180. Am J Physiol 257, G202-G209.
31. Schwartz GJ, McHugh PR & Moran TH (1991). Integration of vagal afferent responses to gastric loads and cholecystokinin in rats. Am J Physiol 261, R64-R69.
32. Schwartz GJ & Moran TH (1998). Duodenal nutrient exposure elicits nutrient-specific gut motility and vagal afferent signals in rat. Am J Physiol 274, R1236-R1242.
33. Schwartz GJ, Tougas G & Moran TH (1995). Integration of vagal afferent responses to duodenal loads and exogenous CCK in rats. Peptides 16, 707-711.
34. Smith G, Jerome C, Bushin BJ, Eterno R & Simansky KJ (1981). Abdominal vagotomy blocks the satiety effects of cholecystokinin in the rat. Science 213, 1036-1037.
35. Stark HA, Sharp CM, Sutliff VE, Martinez J, Jensen RT & Gardner JD (1989). CCK-JMV-180: a protein that distinguishes high-affinity cholecystokinin receptors from low-affinity cholecystokinin receptors. Biochim Biophys Acta 1010, 145-150.
36. Talley NJ (2003). Pharmacologic therapy for the irritable bowel syndrome. Am J Gastroenterol 98, 750.
37. Tsunoda Y & Owyang C (1995). High-affinity CCK receptors are coupled to phospholipase A2 pathways to mediate pancreatic amylase secretion. Am J Physiol 269, G435-G444.
38. Weatherford SC, Laughton WB, Salabarria J, Danho W, Tilley JW, Netterville LA, Schwartz GJ & Moran TH (1993). CCK satiety is differentially mediated by high- and low-affinity CCK receptors in mice and rats. Am J Physiol 264, R244-R249.
39. Zhu JX, Wu XY, Owyang C & Ying L (2001). Intestinal serotonin acts as a paracrine substance to mediate vagal transmission evoked by luminal factors in the rat. J Physiol 530, 431-442.